AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by da Costa, K.-A.
Right arrow Articles by Zeisel, S. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by da Costa, K.-A.
Right arrow Articles by Zeisel, S. H
Agricola
Right arrow Articles by da Costa, K.-A.
Right arrow Articles by Zeisel, S. H
American Journal of Clinical Nutrition, Vol. 81, No. 2, 440-444, February 2005
© 2005 American Society for Clinical Nutrition

ORIGINAL RESEARCH COMMUNICATION

Choline deficiency in mice and humans is associated with increased plasma homocysteine concentration after a methionine load1,2,3,4

Kerry-Ann da Costa, Christopher E Gaffney, Leslie M Fischer and Steven H Zeisel

1 From the Department of Nutrition, School of Public Health and School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill

2 Presented in part in poster form at Experimental Biology 2004, Washington, DC (FASEB J 2004;18:A5410).

3 Supported by a grant from the National Institutes of Health (DK55865) and by grants from the NIH to the University of North Carolina Clinical Nutrition Research Unit (DK56350), General Clinical Research Center (RR00046), and the Center for Environmental Health and Susceptibility (ES10126).

4 Address reprint requests to SH Zeisel, Department of Nutrition, School of Public Health and School of Medicine, University of North Carolina at Chapel Hill, CB# 7461, Chapel Hill, NC 27599. E-mail: steven_zeisel{at}unc.edu.


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Background: Elevated concentrations of homocysteine in blood may be an independent risk factor for the development of atherosclerosis. Elevated homocysteine concentrations can be caused by decreased methylation of homocysteine to form methionine, as occurs in folate deficiency. A parallel pathway exists for methylation of homocysteine, in which choline, by way of betaine, is the methyl donor.

Objective: Our goal was to determine whether choline deficiency results in a decreased capacity to methylate homocysteine.

Design: C57BL/6J mice were fed diets containing 0, 10, or 35 mmol choline/kg diet for 3 wk. We then administered an oral methionine load to the animals and measured plasma homocysteine concentrations. Also, in a pilot study, we examined 8 men who were fed a diet providing 550 mg choline/d per 70 kg body weight for 10 d, followed by a diet providing almost no choline, until the subjects were clinically judged to be choline deficient or for ≤42 d. A methionine load was administered at the end of each dietary phase.

Results: Two hours after the methionine load, choline-deficient mice had plasma homocysteine concentrations twice those of choline-fed mice. Four hours after the methionine load, clinically choline-depleted men had plasma homocysteine concentrations that were 35% greater than those in men not choline depleted.

Conclusion: These results suggest that choline, like folate, plays an important role in the metabolism of homocysteine in humans and that response to a methionine load may be useful when assessing choline nutriture.

Key Words: Choline deficiency • methionine load • homocysteine • mice • humans


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Epidemiologic studies have shown that an elevated total plasma homocysteine concentration is correlated with an increased risk of atherosclerotic vascular disease (1, 2). Homocysteine is metabolized by conversion to sulfur amino acids, and mutations in cystathionine ß-synthase, the catabolic enzyme that requires vitamin B-6, result in hyperhomocysteinemia (3). In addition, homocysteine can be methylated to form methionine (3) by 2 parallel pathways, both of which lower homocysteine concentrations. In the first pathway, vitamin B-12 and folic acid are involved in a reaction catalyzed by methionine synthase (4). Deficiency of these nutrients (5, 6), or single nucleotide polymorphisms in the genes for the enzymes involved in this pathway (4, 6, 7), can result in elevated plasma homocysteine concentrations. The alternative pathway for the methylation of homocysteine to form methionine is catalyzed by betaine homocysteine methyltransferase (8), an enzyme whose activity was reported to increase in rats during methionine excess (9). Betaine, derived from dietary choline, is the methyl group donor in this reaction, and supplemental oral betaine can lower plasma homocysteine concentrations (10, 11). Choline is an essential nutrient (12), and humans can become depleted of it (13, 14). In this study we examined whether dietary choline deficiency was associated with a decreased capacity to methylate homocysteine and whether it results in elevated plasma homocysteine concentrations.


   MATERIALS AND METHODS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
RESULTS
 DISCUSSION
 REFERENCES
 
Materials
DL-Homocysteine, cysteamine, reduced glutathionine, and SBD-F (7-fluorobenzo-2-oxa-1,3-diazole-4-sulfonic acid, ammonium salt) were purchased from Sigma Chemical Co (St Louis). L-Cysteine came from Aldrich (Milwaukee), and TCEP-HCl [tris (2-carboxyethyl) phosphine hydrochloride] was obtained from Pierce (Rockford, IL). The other reagents were obtained from Fisher Scientific (Fair Lawn, NJ).

Animals and diets
All animal procedures were approved by the University of North Carolina Institutional Animal Care and Use Committee. Male C57BL/6J mice (Jackson Labs, Bar Harbor, ME), 25 g body weight, were housed individually in tubs in a climate-controlled room (24 °C) exposed to light from 0600 to 1800 daily. They were given free access to water and pelleted diets (Dyets, Bethlehem, PA) for 3 wk. Three AIN-93G diets were used, containing 35 mmol choline/kg diet (choline supplemented, CS), 10 mmol choline/kg diet (control), or 0 mmol choline/kg diet (choline deficient, CD). These AIN-93G diets contained 5.2 g methionine/kg, 2 mg folate/kg, 7 mg vitamin B-6/kg, and 0.025 mg vitamin B-12/kg, which meets the rodent requirement for these nutrients (15).

For the study in mice, on the morning of the last day of the diet period, half of the mice in each group (n = 7/group in CD; n = 5/group in control and CS mice) were anesthetized (200 mg ketamine/kg and 16 mg xylazine/kg), and blood was collected by cardiac puncture. Heparin was added to the sample, and the plasma was separated by centrifugation (1000 x g for 10 min at 4 °C). The livers from the exsanguinated mice were then collected by freeze-clamping them with tongs precooled in liquid nitrogen, and the animals died. All the samples were then stored at –80 °C until further analysis. L-Methionine was administered to the remaining animals by oral gavage at a dose of 100 mg/kg body weight. Two hours later, these mice were anesthetized and exsanguinated by cardiac puncture, plasma and livers were collected and stored as stated above, and the mice died. Homocysteine was measured 2 h after the methionine load in the mice because previous work in rats indicated a maximal response by that time (16).

Human study
Eight healthy male volunteers aged 20–46 y (5 whites and 3 African Americans) with body mass indexes (in kg/m2) ranging from 20 to 33, were recruited for a protocol approved by the Institutional Review Board at the University of North Carolina at Chapel Hill. Subjects were admitted to the General Clinical Research Center and administered various research diets. A description of these diets has been published elsewhere (17, 18). Specifically, subjects were fed for 10 d a baseline diet of normal foods containing 550 mg choline/d per 70 kg body weight, which is approximately the current presumed adequate intake (12); the choline content of the diet was assayed by our laboratory (19). On the morning of day 10, a blood sample was collected from the subjects. Then the subjects were given L-methionine (100 mg/kg body weight) orally, and 4 h later blood was collected for the measurement of homocysteine concentrations. Subjects were then switched to a choline depletion diet containing <50 mg choline/d per 70 kg body weight for ≤42 d or until they were judged to be choline deficient [developed hepatic steatosis, as measured by magnetic resonance imaging (MRI)]. On the morning after subjects were determined to be choline deficient, or after 42 d on the experimental diet, a blood sample was collected from subjects. Then they were given L-methionine (100 mg/kg body weight) orally, and 4 h later blood was collected for the measurement of homocysteine concentrations. After these measurements, subjects not deemed to be clinically choline deficient by MRI were fed the 550-mg choline diet for 3 d and then discharged. Subjects deemed to be clinically choline deficient were fed diets containing graded amounts of choline (sequentially in 10-d periods; containing 138, 275, 413, or 550 mg choline/d per 70 kg body weight) until hepatic steatosis resolved by MRI and they were judged not to be clinically choline deficient. These subjects, on the last day of the repletion diet, were given L-methionine orally (100 mg/kg body weight), and 4 h later blood was collected and homocysteine concentrations were measured.

The diets were composed of 0.8 g high-biologic-value protein/kg body weight, with 30% kcal coming from fat and the remaining kcal from carbohydrate. The diets met or exceeded the estimated average requirement for methionine plus cysteine and the daily reference intake for vitamin B-6, vitamin B-12, and folate (400 dietary folate equivalents/d).

Analytic methods
We used an HPLC method to measure total plasma homocysteine concentrations (20). We used a Dynamax HPLC system (model SD-200; Rainin Instruments, Woburn, MA) with a Microsorb-MV C18 column (5 µm, 100 A, 25 cm; Varian Inc, Walnut Creek, CA) and fluorescence spectrophotometric detector (Varian Prostar model 360) at EX 385 nm, EM 515 nm wavelength. Cysteamine was the internal standard used to correct for recovery. Blood samples from the human study also were analyzed by an independent laboratory at the University of Colorado Health Sciences Center (Denver) with use of gas chromatography–mass spectrometry methods to confirm plasma homocysteine concentrations (21).

Choline and metabolites, folate, and triacylglycerols
Choline and its metabolites were extracted from liver tissue and human plasma by the method of Bligh and Dyer (22). Aqueous and organic compounds were separated, analyzed, and quantified directly by HPLC-mass spectrometry (liquid chromatography and electrospray ionization–isotope dilution mass spectrometry) after the addition of internal standards labeled with stable isotopes that were used to correct for recovery (23). Plasma folate concentrations were measured with the use of a microbiological assay (24). Lipids were extracted from mouse liver tissue by the method of Bligh and Dyer (22), dried, and resuspended in 100 µL isopropanol, 1% Triton X-100 for ≥1 h. Triacylglycerols were quantified against a standard with use of the Stanbio enzymatic colorimetric triacylglycerol assay (Boerne, TX).

Statistical analysis
In the mouse study, significant differences between fasting and methionine load homocysteine concentrations in plasma were determined by Student's t test. Data were analyzed by two-factor analysis of variance (ANOVA) with interaction to determine whether differences in methionine-load status varied by diet. Differences among the 6 groups defined by combinations of methionine-load status and diet were determined by using 1-factor ANOVA and the Tukey-Kramer critical difference test. In the human study, for each metabolite, a two-sample t test based on the differences between the metabolite concentrations for the 2 diets was used to compare the clinically depleted and the not depleted groups. Significant differences between the diets were determined by paired t test, and 95% CIs were calculated for changes in homocysteine concentration by depletion status. Statistics were performed with the use of JMP software, version 3.2 (SAS Institute Inc, Cary, NC).


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
DISCUSSION
 REFERENCES
 
The mean (±SE) homocysteine concentration in mouse plasma at the beginning of our study was 4.4 ± 0.6 µmol/L (n = 4), which was similar to published values (25). After 3 wk of the various diets, no significant difference was observed in plasma homocysteine concentrations between the CS (4.4 ± 0.4 µmol/L; n = 5), control (4.8 ± 0.2 µmol/L; n = 5), and CD (4.2 ± 0.2 µmol/L; n = 7) groups (Figure 1Go, hatched bars). There was, however, a significant interaction between methionine-load status and diet (P < 0.001). In choline-fed mice (control + CS groups), an oral dose of methionine increased plasma homocysteine concentrations at least 2-fold 2 h after the dose compared with mice not given a methionine load (4.6 ± 0.7 compared with 11.4 ± 3.9 µmol/L; P < 0.01, Student's t test; Figure 1Go). After a methionine load, CD mice had plasma homocysteine concentrations 5 times (25.0 ± 3.7 µmol/L; P < 0.01, Student's t test; Figure 1Go, solid bars) those of CD mice not given a methionine load and twice those in the CS (12.6 ± 2.3 µmol/L) and control (10.2 ± 1.1 µmol/L; P < 0.01, ANOVA; Figure 1Go solid bars) mice given a methionine load.



View larger version (24K):
[in this window]
[in a new window]
  		FIGURE 1. Mean (±SE) plasma homocysteine concentrations in mice fed AIN-93G diets containing 0 (choline deficient, CD), 10 (control, C), or 35 (choline supplemented, CS) mmol choline/kg diet for 3 wk followed by a methionine load (100 mg/kg body weight). Blood was collected, plasma was separated, and homocysteine concentrations were measured by HPLC before (cross-hatched bars) and 2 h after (solid bars) the methionine load; n = 5–7/group. There was a significant (P < 0.001) methionine-load status x diet interaction. *Significantly different from fasting (no methionine load), P < 0.01 (Student's t test). #Significantly different from all other groups, P < 0.01 (ANOVA and Tukey-Kramer test).

 
After 3 wk on the experimental diets, livers from the CD mice had 68% less phosphocholine (Table 1Go; P < 0.001, Student's t test), 38% less choline (P < 0.05), and 14% less phosphatidylcholine (P < 0.01) than livers from the mice fed 10 mmol choline/kg diet. Concentrations of other metabolites of choline such as betaine, glycerophosphocholine, and sphingomyelin did not change with choline deficiency (Table 1Go), nor did hepatic triacylglycerols (Table 1Go; P = 0.142, Student's t test). Plasma folate concentrations were within the normal range and also did not differ between the groups (Table 1Go; P = 0.867, Student's t test). We previously reported that choline and triacylglycerol data from mice supplemented with 35 mmol choline/kg diet (not shown) were not different from the mice fed 10 mmol choline/kg diet (26).


View this table:
[in this window]
[in a new window]
  		TABLE 1 Liver concentrations of choline and its metabolites in control and choline-deficient mice1

 
In the human study, all 8 subjects on the 550-mg choline baseline diet responded to the methionine load by increasing their mean plasma homocysteine concentration from 6.4 ± 0.6 to 18.5 ± 2.4 µmol/L (P = 0.00053, paired t test). Hepatic steatosis develops in choline-deficient humans because choline moiety is needed to secrete VLDL from liver (13, 27); we selected this as a clinically important marker for functional changes associated with choline deficiency. During the choline-depletion phase, hepatic steatosis was measured by MRI at 21 and 42 d. Four of the subjects on the 50 mg choline depletion diet were judged to be clinically choline depleted (2 at day 21, 2 at day 42) because they developed hepatic steatosis, and 4 subjects were not judged to be clinically depleted by the end of the study (day 42). At the end of the depletion diet phase, fasting plasma homocysteine concentrations (Figure 2Go) increased by 1.3 µmol/L (95% CI: 0.8, 1.8; P = 0.004) in the subjects judged to be clinically choline depleted and increased by 0.8 µmol/L (95% CI: –1.3, 2.9; P = 0.309) in the subjects not deemed to be clinically depleted. After a methionine load (at the end of the depletion diet phase), in the clinically choline-depleted group, plasma homocysteine concentrations rose 5.2 µmol/L (95% CI: 1.2, 9.1; P = 0.025; Figure 2Go) above that which was previously observed after a methionine load with the 550-mg choline diet. After a methionine load (at the end of the depletion diet phase), in the group that was not judged to be clinically choline depleted, plasma homocysteine concentrations did not increase above the amounts previously observed when subjects were on the 550-mg diet and received a methionine load (–0.3 µmol/L; 95% CI: –3.5, 2.87; P = 0.761). By two-sample t test, there was a significant interaction between methionine load and clinical status (P = 0.014). After choline-deficient subjects consumed the repletion diets and were found to no longer have hepatic steatosis, plasma homocysteine concentrations returned to baseline values (6.5 ± 0.4 µmol/L), and response to a methionine load was not different from that seen on the 550-mg diet (increasing to homocysteine of 15.2 ± 1.5 µmol/L after the load).



View larger version (19K):
[in this window]
[in a new window]
  		FIGURE 2. Change ({Delta}) in plasma homocysteine (Hcy) concentrations in 8 healthy men fed a 550-mg choline baseline diet for 10 d, followed by a 50-mg choline depletion diet for ≤42 d, before and after a methionine load (100 mg/kg body weight). Subjects with hepatic steatosis (n = 4) were judged to be clinically choline depleted (D) and were offered a repletion diet until hepatic steatosis resolved. Subjects without hepatic steatosis at the end of the depletion phase (n = 4) were deemed not to be depleted (ND). Plasma Hcy was measured at the end of each phase before and 4 h after the methionine load. Hcy concentrations rose from 6.4 ± 0.6 µmol/L before the methionine load to 18.5 ± 2.4 µmol/L after the methionine load in men fed the 550-mg diet (n = 8; P < 0.001, paired t test). A significant (P < 0.05) interaction was observed between methionine load and clinical status. The change in Hcy concentration was calculated as follows: depletion diet –550-mg diet. Brackets represent 95%CIs.

 
In all 8 human subjects, plasma choline and betaine concentrations fell 30% and 47%, respectively, at the end of the depletion phase (Table 2Go; P < 0.005, paired t test). Subjects who were judged to be clinically depleted had decreases in plasma choline and betaine concentrations that were not different from those observed in subjects not deemed to be clinically depleted (Table 2Go). Phosphatidylcholine concentrations in plasma did not change significantly with the diet (Table 2Go; P = 0.304, paired t test), nor did plasma folate concentrations (Table 2Go; P = 0.233, paired t test).


View this table:
[in this window]
[in a new window]
  		TABLE 2 Plasma concentrations of choline and its metabolites in humans fed a choline-deficient diet or a diet providing 550 mg choline/d1

 

   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
REFERENCES
 
The present study shows that, among its other functions, choline may be important for lowering plasma homocysteine concentrations even when dietary consumption of folate and other B vitamins is adequate. In our mouse study, for a better comparison with the human study, we used AIN 93G diets for the animals [instead of the more restrictive diets we used in the past that limited folate and methionine as well as choline (28)] and this depleted liver choline compounds but did not cause hepatic steatosis in mice. With this mild choline depletion, the plasma homocysteine concentrations in all the groups at 3 wk on experimental diets were not significantly different from each other. This latter observation was noted by others (29). This modest choline depletion could not be detected by only measuring plasma homocysteine concentrations in the absence of a methionine load. This lack of detection was probably because, when homocysteine flux is low, the folate-dependent methylation pathways are sufficient for homocysteine removal. We used a methionine load test to increase homocysteine synthesis and consequently to test the capacity of the homocysteine catabolic system under stress. Mice given a methionine load had almost 3-fold higher plasma homocysteine concentrations than mice not given a methionine load. The increase in homocysteine concentration after load was significantly higher in the CD mice than the other groups. Thus, when homocysteine flux was high, folate-dependent methylation was limiting and choline-betaine dependent methylation became critical.

In the human study, the diets similarly contained the recommended daily amounts of folate and B vitamins. Half of the subjects fed a choline-deficient diet eventually became clinically symptomatic of choline depletion (developing hepatic steatosis). The fasting plasma homocysteine concentrations in these depleted humans were increased more than in individuals who were judged not to be clinically depleted. This difference was even greater after a methionine load. Thus, in both mice and humans we showed that, when homocysteine flux was high, folate-dependent methylation was limiting and choline-betaine dependent methylation became critical.

We do not understand why half of the human subjects did not develop hepatic steatosis while on a choline-deficient diet. We hypothesized that their endogenous synthesis of choline by way of phosphatidylethanolamine N-methyltransferase (30) may have been greater than that in the subjects who did develop steatosis. It is important to note that measurement of plasma choline or betaine concentrations was not sufficient to predict which subjects would develop organ dysfunction, because all depleted subjects had low plasma choline and betaine concentrations. We were able to identify subjects who were sufficiently depleted of choline so as to develop hepatic steatosis by using a methionine-loading test. Also, this test would yield yet another important indicator, betaine after a methionine load, which was found in a recent report (9) to have a strong inverse association with the increase in homocysteine after methionine load. We suggest that clinicians use this test as a complement to plasma choline concentrations to identify patients who are clinically choline depleted. For example, the methionine-load test would be useful for evaluating patients fed total parenteral nutrition who become choline depleted and can develop steatosis (14, 31–33). If it is known that the patient has normal plasma or erythrocyte folate concentrations, a plasma choline determination and a methionine-loading test could predict which patients are likely to be at risk of organ dysfunction associated with choline deficiency. We suggest that it would be this group that would be most responsive to treatment with a supplemental source of choline (14).

Our study showed that when homocysteine flux is high, the folate-dependent pathway for methylation of homocysteine is limiting and the choline-betaine–dependent pathway becomes important; this finding is consistent with the conclusions of other investigators (9). On the basis of this information, we suggest that the methionine-load test is useful for detecting choline deficiency in humans.


   ACKNOWLEDGMENTS
 
We thank Umadevi Veluvolu for performing the homocysteine analyses with the human samples and Larry Kupper for his help with the statistical analyses.

KAd-C participated in the design of the studies, planned and executed the animal experiments, supervised blood collection and processing, participated in the statistical analyses and data interpretation, and was responsible for writing the manuscript. CEG validated the homocysteine assay, analyzed the mouse samples, and provided significant input in the writing of the manuscript. LMF participated in the design and supervision of the human study and the recruitment of patients. SHZ was responsible for the design of the human study, participated in the statistical analyses and data interpretation, and provided significant input in the writing of the manuscript. None of the authors had a financial conflict of interest in relation to this study.


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Melenovsky V, Stulc T, Kozich V, et al. Effect of folic acid on fenofibrate-induced elevation of homocysteine and cysteine. Am Heart J 2003;146:110.[Medline]
  2. Glueck CJ, Shaw P, Lang JE, Tracy T, Sieve-Smith L, Wang Y. Evidence that homocysteine is an independent risk factor for atherosclerosis in hyperlipidemic patients. Am J Cardiol 1995;75:132-6.[Medline]
  3. Finkelstein JD. Pathways and regulation of homocysteine metabolism in mammals. Semin Thromb Haemost 2000;26:219-25.[Medline]
  4. Weisberg IS, Jacques PF, Selhub J, et al. The 1298A->C polymorphism in methylenetetrahydrofolate reductase (MTHFR): in vitro expression and association with homocysteine. Atherosclerosis 2001;156:409-15.[Medline]
  5. Shelnutt KP, Kauwell GP, Chapman CM, et al. Folate status response to controlled folate intake is affected by the methylenetetrahydrofolate reductase 677C->T polymorphism in young women. J Nutr 2003;133:4107-11.[Abstract/Free Full Text]
  6. Jacques PF, Bostom AG, Wilson PW, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001;73:613-21.[Abstract/Free Full Text]
  7. Watkins D, Ru M, Hwang HY, et al. Hyperhomocysteinemia due to methionine synthase deficiency, cblG: structure of the MTR gene, genotype diversity, and recognition of a common mutation, P1173L. Am J Hum Genet 2002;71:143-53.[Medline]
  8. Sunden S, Renduchintala M, Park E, Miklasz S, Garrow T. Betaine-homocysteine methyltransferase expression in porcine and human tissues and chromosomal localization of the human gene. Arch Biochem Biophys 1997;345:171-4.[Medline]
  9. Holm PI, Bleie O, Ueland PM, et al. Betaine as a determinant of postmethionine load total plasma homocysteine before and after B-vitamin supplementation. Arterioscler Thromb Vasc Biol 2004;24:301-7.[Abstract/Free Full Text]
  10. Steenge GR, Verhoef P, Katan MB. Betaine supplementation lowers plasma homocysteine in healthy men and women. J Nutr 2003;133:1291-5.[Abstract/Free Full Text]
  11. Wendel U, Bremer H. Betaine in the treatment of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency. Eur J Pediatr 1984;142:147-50.[Medline]
  12. Institute of Medicine, National Academy of Sciences USA. Dietary reference intakes for folate, thiamin, riboflavin, niacin, vitamin B-12, panthothenic acid, biotin, and choline. Washington, DC: National Academy Press, 1998.
  13. Zeisel SH, daCosta K-A, Franklin PD, et al Choline, an essential nutrient for humans. FASEB J 1991;5:2093-8.[Abstract]
  14. Buchman AL, Ament ME, Sohel M, et al. Choline deficiency causes reversible hepatic abnormalities in patients receiving parenteral nutrition: proof of a human choline requirement: a placebo-controlled trial. JPEN J Parenter Enteral Nutr 2001;25:260-8.[Abstract]
  15. Reeves PG, Nielsen FH, Fahey GC Jr. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc committee on reformulation of the AIN-76A rodent diet. J Nutr 1993;123:1939-51.
  16. Miller JW, Nadeau MR, Smith D, Selhub J. Vitamin B-6 deficiency vs folate deficiency: comparison of responses to methionine loading in rats. Am J Clin Nutr 1994;59:1033-9.[Abstract/Free Full Text]
  17. Busby M, Fischer L, da Costa K, Thompson D, Mar M-H, Zeisel SH. Choline and betaine defined diets for use in clinical research and for the management of trimethylaminuria. J Am Diet Assoc. 2004 (in press).
  18. da Costa K, Badea M, Fischer L, Zeisel S. Elevated serum creatine phosphokinase in choline-deficient humans: mechanistic studies in C2C12 mouse myoblasts. Am J Clin Nutr 2004;80:163-70.[Abstract/Free Full Text]
  19. Zeisel SH, Mar MH, Howe JC, Holden JM. Concentrations of choline-containing compounds and betaine in common foods. J Nutr 2003;133:1302-7.[Abstract/Free Full Text]
  20. Ubbink JB, Hayward Vermaak WJ, Bissbort S. Rapid high-performance liquid chromatographic assay for total homocysteine levels in human serum. J Chromatogr 1991;565:441-6.[Medline]
  21. Stabler SP, Lindenbaum J, Allen RH. The use of homocysteine and other metabolites in the specific diagnosis of vitamin B-12 deficiency. J Nutr 1996;126:1266S-72S.
  22. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911-7.
  23. Koc H, Mar MH, Ranasinghe A, Swenberg JA, Zeisel SH. Quantitation of choline and its metabolites in tissues and foods by liquid chromatography/electrospray ionization-isotope dilution mass spectrometry. Anal Chem 2002;74:4734-40.[Medline]
  24. Horne DW, Patterson D. Lactobacillus casei microbiological assay of folic acid derivatives in 96-well microtiter plates. Clin Chem 1988;34:2357-9.[Abstract/Free Full Text]
  25. Gimenez R, Aguilar J. Effects of cytidine 5-diphosphocholine on plasma homocysteine levels in rat. Comp Biochem Physiol B Biochem Mol Biol 2003;134:271-6.[Medline]
  26. Zhu X, Song J, Mar MH, Edwards LJ, Zeisel SH. Phosphatidylethanolamine N-methyltransferase (PEMT) knockout mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline. Biochem J 2003;370:987-93.[Medline]
  27. Yao ZM, Vance DE. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem 1988;263:2998-3004.[Abstract/Free Full Text]
  28. da Costa K, Cochary EF, Blusztajn JK, Garner SC, Zeisel SH. Accumulation of 1,2-sn-diradylglycerol with increased membrane-associated protein kinase C may be the mechanism for spontaneous hepatocarcinogenesis in choline deficient rats. J Biol Chem 1993;268:2100-5.[Abstract/Free Full Text]
  29. Svardal AM, Ueland PM, Berge RK, et al. Effect of methotrexate on homocysteine and other compounds in tissues of rats fed a normal or a defined, choline-deficient diet. Cancer Chemother Pharmacol 1988;21:313-8.[Medline]
  30. Bremer J, Figard PH, Greenberg DM. The biosynthesis of choline and its relation to phospholipid metabolism. Biochim Biophys Acta 1960;43:477-88.
  31. Sheard NF, Tayek JA, Bistrian BR, Blackburn GL, Zeisel SH. Plasma choline concentration in humans fed parenterally. Am J Clin Nutr 1986;43:219-24.[Abstract/Free Full Text]
  32. Buchman A, Dubin M, Moukarzel A, et al. Choline deficiency: a cause of hepatic steatosis during parenteral nutrition that can be reversed with intravenous choline supplementation. Hepatology 1995;22:1399-403.[Medline]
  33. Buchman AL, Moukarzel A, Jenden DJ, Roch M, Rice K, Ament ME. Low plasma free choline is prevalent in patients receiving long term parenteral nutrition and is associated with hepatic aminotransferase abnormalities. Clin Nutr 1993;12:33-7.
Received for publication July 7, 2004. Accepted for publication October 21, 2004.




This article has been cited by other articles:


Home page
 Physiol. GenomicsHome page
T. Kitami, R. Rubio, W. O'Brien, J. Quackenbush, and J. H. Nadeau
Gene-environment interactions reveal a homeostatic role for cholesterol metabolism during dietary folate perturbation in mice
Physiol Genomics, October 7, 2008; 35(2): 182 - 190.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
K. Veenema, C. Solis, R. Li, W. Wang, C. V Maletz, C. M Abratte, and M. A Caudill
Adequate Intake levels of choline are sufficient for preventing elevations in serum markers of liver dysfunction in Mexican American men but are not optimal for minimizing plasma total homocysteine increases after a methionine load
Am. J. Clinical Nutrition, September 1, 2008; 88(3): 685 - 692.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
S. Dayal and S. R. Lentz
Murine Models of Hyperhomocysteinemia and Their Vascular Phenotypes
Arterioscler. Thromb. Vasc. Biol., September 1, 2008; 28(9): 1596 - 1605.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
C. Signore, P. M. Ueland, J. Troendle, and J. L Mills
Choline concentrations in human maternal and cord blood and intelligence at 5 y of age
Am. J. Clinical Nutrition, April 1, 2008; 87(4): 896 - 902.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. E Chiuve, E. L Giovannucci, S. E Hankinson, S. H Zeisel, L. W Dougherty, W. C Willett, and E. B Rimm
The association between betaine and choline intakes and the plasma concentrations of homocysteine in women
Am. J. Clinical Nutrition, October 1, 2007; 86(4): 1073 - 1081.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. H Zeisel
Nutrigenomics and metabolomics will change clinical nutrition and public health practice: insights from studies on dietary requirements for choline
Am. J. Clinical Nutrition, September 1, 2007; 86(3): 542 - 548.
[Abstract] [Full Text] [PDF]

Home page
 JNCI J Natl Cancer InstHome page
E. Cho, W. C. Willett, G. A. Colditz, C. S. Fuchs, K. Wu, A. T. Chan, S. H. Zeisel, and E. L. Giovannucci
Dietary Choline and Betaine and the Risk of Distal Colorectal Adenoma in Women
J Natl Cancer Inst, August 15, 2007; 99(16): 1224 - 1231.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
M. Resseguie, J. Song, M. D. Niculescu, K.-A. da Costa, T. A. Randall, and S. H. Zeisel
Phosphatidylethanolamine N-methyltransferase (PEMT) gene expression is induced by estrogen in human and mouse primary hepatocytes
FASEB J, August 1, 2007; 21(10): 2622 - 2632.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
M. D Niculescu, K.-A. da Costa, L. M Fischer, and S. H Zeisel
Lymphocyte gene expression in subjects fed a low-choline diet differs between those who develop organ dysfunction and those who do not
Am. J. Clinical Nutrition, July 1, 2007; 86(1): 230 - 239.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
L. M Fischer, K. A. daCosta, L. Kwock, P. W Stewart, T.-S. Lu, S. P Stabler, R. H Allen, and S. H Zeisel
Sex and menopausal status influence human dietary requirements for the nutrient choline
Am. J. Clinical Nutrition, May 1, 2007; 85(5): 1275 - 1285.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
S. H. Zeisel
Response to: DEA in consumer products is safe
FASEB J, January 1, 2007; 21(1): 296 - 297.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
K.-A. da Costa, M. D Niculescu, C. N Craciunescu, L. M Fischer, and S. H Zeisel
Choline deficiency increases lymphocyte apoptosis and DNA damage in humans
Am. J. Clinical Nutrition, July 1, 2006; 84(1): 88 - 94.
[Abstract] [Full Text] [PDF]

Home page
 JPEN J Parenter Enteral NutrHome page
A. L. Buchman, M. E. Ament, D. J. Jenden, and C. Ahn
Choline Deficiency Is Associated With Increased Risk for Venous Catheter Thrombosis
JPEN J Parenter Enteral Nutr, July 1, 2006; 30(4): 317 - 320.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
K.-A. da Costa, O. G. Kozyreva, J. Song, J. A. Galanko, L. M. Fischer, and S. H. Zeisel
Common genetic polymorphisms affect the human requirement for the nutrient choline
FASEB J, July 1, 2006; 20(9): 1336 - 1344.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
M. Collinsova, J. Strakova, J. Jiracek, and T. A. Garrow
Inhibition of Betaine-Homocysteine S-Methyltransferase Causes Hyperhomocysteinemia in Mice
J. Nutr., June 1, 2006; 136(6): 1493 - 1497.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
V. Michel, Z. Yuan, S. Ramsubir, and M. Bakovic
Choline Transport for Phospholipid Synthesis.
Experimental Biology and Medicine, May 1, 2006; 231(5): 490 - 504.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
S. Ratnam, E. P. Wijekoon, B. Hall, T. A. Garrow, M. E. Brosnan, and J. T. Brosnan
Effects of diabetes and insulin on betaine-homocysteine S-methyltransferase expression in rat liver
Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E933 - E939.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
E. Cho, S. H Zeisel, P. Jacques, J. Selhub, L. Dougherty, G. A Colditz, and W. C Willett
Dietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total homocysteine concentration in the Framingham Offspring Study.
Am. J. Clinical Nutrition, April 1, 2006; 83(4): 905 - 911.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
M. Kohlmeier, K.-A. da Costa, L. M. Fischer, and S. H. Zeisel
Genetic variation of folate-mediated one-carbon transfer pathway predicts susceptibility to choline deficiency in humans
PNAS, November 1, 2005; 102(44): 16025 - 16030.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
S. H Zeisel
Choline, homocysteine, and pregnancy
Am. J. Clinical Nutrition, October 1, 2005; 82(4): 719 - 720.
[Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
A. M Molloy, J. L Mills, C. Cox, S. F Daly, M. Conley, L. C Brody, P. N Kirke, J. M Scott, and P. M Ueland
Choline and homocysteine interrelations in umbilical cord and maternal plasma at delivery
Am. J. Clinical Nutrition, October 1, 2005; 82(4): 836 - 842.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by da Costa, K.-A.
Right arrow Articles by Zeisel, S. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by da Costa, K.-A.
Right arrow Articles by Zeisel, S. H
Agricola
Right arrow Articles by da Costa, K.-A.
Right arrow Articles by Zeisel, S. H

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS